NMR-based metabolic profiling of urine, serum, fecal, and pancreatic tissue samples from the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer.
Pancreatic cancer is the third leading cause of cancer deaths in the United States with more than 53,000 expected to be diagnosed with the disease in 2018. The median survival time after diagnosis is four to six months. The poor survival statistics are due in part to the fact that pancreatic cancer...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Public Library of Science (PLoS)
2018-01-01
|
| Серія: | PLoS ONE |
| Онлайн доступ: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0200658&type=printable |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|